Evidence map›Paper›PMID 25114122›Full record

ArticleInfection and immunity2014

Role of pathogen-derived cell wall carbohydrates and prostaglandin E2 in immune response and suppression of fish immunity by the oomycete Saprolegnia parasitica.

Rodrigo Belmonte, Tiehui Wang, Gary J Duncan, Ida Skaar, Hugo Mélida, Vincent Bulone, Pieter van West, Christopher J Secombes

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. A PAX6-regulated receptor tyrosine kinase pairs with a pseudokinase to activate immune defense upon oomycete recognition inProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Transcriptome Analysis ofInternational journal of molecular sciences · 2020
    Article
  11. Article
  12. Article
  13. Mycobiology · 2017
    Article
  14. Article
  15. Review
  16. Emerging oomycete threats to plants and animals.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2016
    Review
  17. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Rodrigo BelmonteScottish Fish Immunology Research Centre, Institute of Biological and Environmental Sciences, University of Aberdeen, Aberdeen, United Kingdom Aberdeen Oomycete Laboratory, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.
Tiehui WangScottish Fish Immunology Research Centre, Institute of Biological and Environmental Sciences, University of Aberdeen, Aberdeen, United Kingdom.
Gary J DuncanMass Spectrometry Group, Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, United Kingdom.
Ida SkaarNorwegian Veterinary Institute, Oslo, Norway.
Hugo MélidaDivision of Glycoscience, School of Biotechnology, Royal Institute of Technology, Stockholm, Sweden.
Vincent BuloneDivision of Glycoscience, School of Biotechnology, Royal Institute of Technology, Stockholm, Sweden.
Pieter van WestAberdeen Oomycete Laboratory, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.
Christopher J SecombesScottish Fish Immunology Research Centre, Institute of Biological and Environmental Sciences, University of Aberdeen, Aberdeen, United Kingdom c.secombes@abdn.ac.uk.
University of Aberdeen · GBKTH Royal Institute of Technology · SENorwegian Veterinary Institute · NO

Funding

Biotechnology and Biological Sciences Research Council BB/G012075/1
6 · The paper itself

Abstract

Saprolegnia parasitica is a freshwater oomycete that is capable of infecting several species of fin fish. Saprolegniosis, the disease caused by this microbe, has a substantial impact on Atlantic salmon aquaculture. No sustainable treatment against saprolegniosis is available, and little is known regarding the host response. In this study, we examined the immune response of Atlantic salmon to S. parasitica infection and to its cell wall carbohydrates. Saprolegnia triggers a strong inflammatory response in its host (i.e., induction of interleukin-1β1 [IL-1β1], IL-6, and tumor necrosis factor alpha), while severely suppressing the expression of genes associated with adaptive immunity in fish, through downregulation of T-helper cell cytokines, antigen presentation machinery, and immunoglobulins. Oomycete cell wall carbohydrates were recognized by fish leukocytes, triggering upregulation of genes involved in the inflammatory response, similar to what is observed during infection. Our data suggest that S. parasitica is capable of producing prostaglandin [corrected] E2 (PGE2) in vitro, a metabolite not previously shown to be produced by oomycetes, and two proteins with homology to vertebrate enzymes known to play a role in prostaglandin biosynthesis have been identified in the oomycete genome. Exogenous PGE2 was shown to increase the inflammatory response in fish leukocytes incubated with cell wall carbohydrates while suppressing genes involved in cellular immunity (gamma interferon [IFN-γ] and the IFN-γ-inducible protein [γ-IP]). Inhibition of S. parasitica zoospore germination and mycelial growth by two cyclooxygenase inhibitors (aspirin and indomethacin) also suggests that prostaglandins may be involved in oomycete development.

Indexed as

Oncorhynchus mykissSalmo salarAnimalsCarbohydratesCell WallDinoprostoneFish DiseasesGene Expression Regulation, EnzymologicGillsHead KidneyInfectionsPhospholipasesSaprolegniaCarbohydratesDinoprostonePhospholipases

Identifiers

PMID25114122
PMCPMC4249338
OpenAlexW2125574424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.